Immunodermatology News

BOSTON — Surgical deroofing is a safe and effective technique for the management of hidradenitis suppurativa, according to a study presented at the American Academy of Dermatology Annual Meeting.

In this video, Christopher Sayed, MD, noted the “increased buzz” around hidradenitis suppurativa at the American Academy of Dermatology Annual Meeting.

In this video, Christopher Sayed, MD, spoke with Healio about the HS Surgery from Start to Finish: Planning, Procedures and Post-Op Care session at the American Academy of Dermatology Annual Meeting.

In this video, Christopher Sayed, MD, highlighted a presentation from the American Academy of Dermatology Annual Meeting that focused on improving the experience of patients with hidradenitis suppurativa when they enter dermatology offices.

In this video, Christopher Sayed, MD, discusses “pearls” from the advanced management of hidradenitis suppurativa symposium at the American Academy of Dermatology Annual Meeting.

March is Autoimmune Awareness Month, and rheumatology organizations have been using their reach and influence on social media sites to spread the word and help patients with autoimmune diseases find community.

Improving basic diet and wellness habits, along with treatment of flares with clindamycin 1%, are some of the recommended approaches to minimizing severe complications of hidradenitis suppurativa, according to recent findings.

Patients had high rates of satisfaction and manageable pain after receiving in-clinic surgery for hidradenitis suppurativa, according to a study.

Etanercept was associated with reduced drug survival rates compared with other biologic therapies used to treat hidradenitis suppurativa, according to a study.

Priority review of a supplemental new drug application for ruxolitinib for the treatment of vitiligo has been accepted by the FDA, Incyte announced in a press release.